The Paris, France, Adminsitrative Tribunal has annulled the nomination of the entire board of the National Sickness Insurance Fund (CNAM), in a decision that puts the past four years of that body's administration into question. The ruling means that the government has been forced to appoint a provisional board, with virtually the same membership, to ratify all decisions taken since the end of October 2004.
The dispute arose over a complaint lodged in 2005 by the French Insurance Companies' Federation (FFSA) over the decision by the then government to nominate a member of the UNSA labor union to the CNAM's board. The political move was due to the UNSA's inability to be represented on the CNAM to speak for salaried workers, because this was restricted to other recognized labor and management organizations.
According to the financial daily newspaper Les Echos, the Tribunal's decision in late March this year caught everyone by surprise, even more so given that the ruling did not merely exclude the UNSA member, but revoked the entire 35-member board's legitimacy.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze